the psychedelic investor

Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin
November 4, 2021June 2, 2024 Business, Learn, Research

Compass Pathways (Nasdaq: CMPS) has announced the launch of a…
Why Psychedelic Stocks Have Crashed in the Last 3 Months
October 13, 2021June 2, 2024 Business, Learn

Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.